0001144204-18-053879.txt : 20181015
0001144204-18-053879.hdr.sgml : 20181015
20181015194959
ACCESSION NUMBER: 0001144204-18-053879
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181012
FILED AS OF DATE: 20181015
DATE AS OF CHANGE: 20181015
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DRISCOLL FREDERICK W
CENTRAL INDEX KEY: 0001129890
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36598
FILM NUMBER: 181123371
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cellectar Biosciences, Inc.
CENTRAL INDEX KEY: 0001279704
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043321804
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3301 AGRICULTURE DRIVE
CITY: MADISON
STATE: WI
ZIP: 53716
BUSINESS PHONE: (608) 441-8120
MAIL ADDRESS:
STREET 1: 3301 AGRICULTURE DRIVE
CITY: MADISON
STATE: WI
ZIP: 53716
FORMER COMPANY:
FORMER CONFORMED NAME: NOVELOS THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20050617
FORMER COMPANY:
FORMER CONFORMED NAME: COMMON HORIZONS INC
DATE OF NAME CHANGE: 20040211
4
1
tv504844_form4.xml
FORM 4
X0306
4
2018-10-12
0
0001279704
Cellectar Biosciences, Inc.
CLRB
0001129890
DRISCOLL FREDERICK W
C/O CELLECTAR BIOSCIENCES, INC.
3301 AGRICULTURE DRIVE
MADISON
WI
53716
1
0
0
0
Stock option (right to buy)
2.61
2018-10-12
4
A
0
13000
0
A
2028-10-12
Common Stock
13000
13000
D
This option grant was divided into a definitive grant of 6,150 shares, which vest in equal monthly installments over a seven month period from the grant date, and a contingent grant of 6,850 shares, which are subject to the following conditions: (i) approval by Cellectar's stockholders of an increase in shares available under the Amended and Restated 2015 Stock Incentive Plan at the Corporation's 2019 annual meeting of stockholders or other special meeting of stockholders called for such purpose; and (ii) to the extent stockholder approval is received, the contingent grant shall vest immediately upon such stockholder approval.
/s/ Christina Blakley, attorney-in-fact for Frederick Driscoll
2018-10-15